Principal Investigator, NOVA Medical School
Michel has a master’s in Biochemistry and Pharmacochemistry and obtained his PhD in Molecular Toxicology. He is interested in the role of EV mediated communication in drug metabolism, especially in what concerns chemotherapeutic drug resistance and liver disease.
Fun Fact: he loves jogging along the seashore in the early morning.